Cardiome announces Health Canada approval of AGGRASTAT® high dose bolus regimen
Cardiome Pharma announced the Therapeutic Products Directorate of Health Canada has approved the AGGRASTAT® (tirofiban hydrochloride) 25 mcg/kg (high) dose bolus regimen, as requested under the Company's supplemental New Drug Submission. July 17, 2017